Pulse Biosciences Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Pulse Biosciences, Inc. (PLSE) Misses Q2 EPS by 4c
August 10, 2022 4:19 PM EDTPulse Biosciences, Inc. (NASDAQ: PLSE) reported Q2 EPS of ($0.44), $0.04 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $265 thousand versus the consensus estimate of $439.67 thousand.
For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.
... More